Extensions — US Patent 11419787

To address your request, I will detail the patent term adjustments (PTA), patent term extensions (PTE), continuation applications, divisional applications, related family members, and the projected expiration date for US patent 11419787 based on the provided patent text and general patent law principles.

Patent Term Adjustments (PTA) and Patent Term Extensions (PTE)

The provided patent text for US11419787B2 does not explicitly state any Patent Term Adjustments (PTA) or Patent Term Extensions (PTE) on its face. Typically, PTA is granted to compensate for delays by the USPTO during the prosecution of a patent application and is noted on the front page of the patent. PTEs are generally awarded for delays related to regulatory review of a product before commercial marketing, often relevant for pharmaceutical patents, and require a Patent Term Extension Certificate filed in the patent's file history. Without direct information on the patent's face or its file history, it's not possible to definitively state if any PTA or PTE were awarded.

Continuation and Divisional Applications

US patent 11419787 is explicitly identified as a continuation application. The "CROSS-REFERENCE TO RELATED APPLICATIONS" section states: "This application is a continuation of U.S. patent application Ser. No. 16/538,117 filed Aug. 12, 2019, which is a continuation of U.S. patent application Ser. No. 15/654,180, filed Jul. 7, 2019, now U.S. Pat. No. 10,376,442 issued Aug. 13, 2019, which is a division of U.S. patent application Ser. No. 14/217,208, filed Mar. 14, 2014, now U.S. Pat. No. 9,744,098 issued Aug. 29, 2017, which is a continuation of U.S. U.S. patent application Ser. No. 12/426,762, filed Apr. 20, 2009, now U.S. Pat. No. 8,676,044 issued Mar. 18, 2014, which is a continuation of U.S. patent Ser. No. 12/205,597 filed on Sep. 5, 2008, now abandoned, which is a continuation-in-part of U.S. patent application Ser. No. 12/051,521, filed Mar. 19, 2008, now U.S. Pat. No. 8,588,593 issued Nov. 19, 2013, the disclosures of each of which are incorporated herein, by reference, in their entirety."

From this, we can delineate the following:

Continuation Applications:
- US 17/133,005 (the application for US11419787) is a continuation of US 16/538,117.
- US 16/538,117 is a continuation of US 15/654,180.
- US 14/217,208 is a continuation of US 12/426,762.
- US 12/426,762 is a continuation of US 12/205,597.
Divisional Applications:
- US 15/654,180 is a division of US 14/217,208. A divisional application typically contains claims to a different invention than that claimed in the parent application, but shares the same specification and priority date.
Continuation-in-Part (CIP) Applications:
- US 12/205,597 is a continuation-in-part of US 12/051,521. A CIP application introduces new subject matter in addition to the parent application's disclosure. Claims related to new matter in a CIP do not benefit from the earlier priority date of the parent.

Related Family Members

The patent family for US 11419787, based on the cross-reference, includes the following US patents and applications:

US 12/051,521 (now U.S. Pat. No. 8,588,593) - Filed Mar. 19, 2008. This is the earliest priority document.
US 12/205,597 (abandoned) - Filed Sep. 5, 2008.
US 12/426,762 (now U.S. Pat. No. 8,676,044) - Filed Apr. 20, 2009.
US 14/217,208 (now U.S. Pat. No. 9,744,098) - Filed Mar. 14, 2014.
US 15/654,180 (now U.S. Pat. No. 10,376,442) - Filed Jul. 7, 2017.
US 16/538,117 - Filed Aug. 12, 2019.
US 17/133,005 (the application for US11419787) - Filed Dec. 23, 2020.
US 2021/0113429 A1 (publication of US17/133,005) - Published April 22, 2021.
US 11690782B2 (priority to US17/820,126) - this seems to be a related patent, granted Aug. 16, 2022, but the relationship type (continuation, divisional) to US11419787 is not explicitly stated in the provided text, only that US11419787 claims priority to US17/820,126.

Projected Expiration Date

For US utility patents filed on or after June 8, 1995, the patent term generally expires 20 years from the filing date of the earliest application for which a benefit is claimed, subject to any patent term adjustments or extensions.

In this case, US 11419787 claims priority back to U.S. patent application Ser. No. 12/051,521, filed Mar. 19, 2008. Therefore, the base 20-year term is calculated from this priority date.

Earliest Priority Date: March 19, 2008
Base Expiration Date (20 years from earliest priority date): March 19, 2028

The patent record lists an "Anticipated expiration" date of 2028-03-19. This aligns with the 20-year term from the earliest priority date (March 19, 2008), suggesting that no significant Patent Term Adjustment (PTA) or Patent Term Extension (PTE) was applied, or if applied, they did not extend the term beyond this date.